It was a pleasure having you. Thanks for sharing a bit about your journey so far Miroslav Gasparek. Excited to continue following your story 🌄

As much as I live and breathe virtual care, it can’t do everything — moles need to be removed. But specifically, how much care CAN be delivered virtually? Christina Farr and I analyzed 9k+ Category I CPT codes to find out. ovsecondopinion.substack.com/p/virtual-care…

Go Kernal + Yusuf Erkul and team!

We're growing - come join us!

Great coverage on advancements in brain organoids and assembloids derived from induced pluripotent stem cells by Sergiu P. Pasca TED Talks! 🧠

Rockstars.

“Unless you appreciate these transformations at the molecular level,” he said, “I don’t think you can be a good physician, and I don’t want you treating patients.” Gotta ask my docs which transformations they do while practicing medicine🧐 nytimes.com/2022/10/03/us/…

Really interesting work - congrats @omerevah and team. Pushing the boundaries

I believe sometimes folks refer to "Techbio" WRT fields outside of making medicines, but I agree that when it comes to medicines... it's "just" biotech.

The human immune system is the best model organism for humans. Looking forward to working with the Infinimmune team!

Happy Holidays from the Civilization VC team! ☃️ We hope that 2023 brings you success and joy. 🌈 Peace. 🕊️ - CV Team Themasap Khan Ruxandra Teslo 🧬 @ Ha

Working with you and the Civilization VC fellows is a highlight of the year!

This is getting ridiculous.

Amazing news, congrats Tamer Mohamed and Aspect Biosystems! Exemplary work in #TissueTherapeutics #RegenMed #CellTherapyIncredibly

only because 2am - 10pm is a wash

One to watch closely. Congrats on the launch Dr. Nicole Paulk.

AI x life sciences: Hype or hope or inevitability? Our firm (Luma Group like n follow!) take on this game-changing intersection, its impact, and VC's role in shaping the future. Read our whitepaper: lumagroup.com/wp-content/upl…

Congrats to this exceptional team of scientists and clinicians at ArsenalBio. It has been inspiring to see the company tackle solid tumors with cellular therapies and we're proud to be investors. The use of living cells as therapies is becoming a bigger reality!